1,2-dimethyl-azepane | 20646-42-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氮杂环庚烷
• 英文名称: 1,2-dimethyl-azepane
• 英文别名: 1,2-dimethyl-hexahydro-azepine；1,2-Dimethyl-hexahydro-azepin；1,2-Dimethylazepane
• CAS: 20646-42-8
• 化学式: C₈H₁₇N
• 分子量: 127.23
• InChiKey: YXXNLFWJYYKFTL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾 、 一水合肼 、 三乙二醇 作用下， 生成 1,2-dimethyl-azepane
  参考文献：
  名称：

  The Kishner Reduction-Elimination. II. α-Substituted Pinacolones^1,2

  摘要：

  DOI：

  10.1021/ja01617a036

文献信息

• [EN] RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE PYRAZOLO- ET TRIAZOLO-PYRIMIDINE ANTIVIRAUX DU VIRUS RESPIRATOIRE SYNCYTIAL (VRS)
  申请人：JANSSEN SCIENCES IRELAND UC

  公开号：WO2016174079A1

  公开（公告）日：2016-11-03

  The invention concerns novel substituted pyrazolo- and triazolo-pyrimidine compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.

  这项发明涉及具有抗病毒活性的新型取代吡唑并三唑基嘧啶化合物，其化学式为(I)，特别是对呼吸道合胞病毒（RSV）复制具有抑制活性。该发明还涉及包含这些化合物的药物组合物，以及用于治疗呼吸道合胞病毒感染的化合物。
• [EN] ACYLGUANIDINES AS TRYPTOPHAN HYDROXYLASE INHIBITORS<br/>[FR] ACYLGUANIDINES COMME INHIBITEURS DE LA TRYPTOPHAN HYDROXYLASE
  申请人：KAROS PHARMACEUTICALS INC

  公开号：WO2015089137A1

  公开（公告）日：2015-06-18

  The present invention is directed to acylguanidines which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPHl), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

  本发明涉及酰基胍，它们是色氨酸羟化酶（TPH）的抑制剂，特别是isoform 1（TPHl），在治疗与外周血清素有关的疾病或紊乱方面具有用处，例如胃肠道、心血管、肺部、炎症、代谢和骨量低等疾病，以及血清素综合征和癌症。
• [EN] PYRIMIDINE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME<br/>[FR] COMPOSES DE PYRIMIDINE ET COMPOSTION DE LUTTE CONTRE LES ANIMAUX NUISIBLES CONTENANT CES COMPOSES
  申请人：SUMITOMO CHEMICAL CO

  公开号：WO2004099160A1

  公开（公告）日：2004-11-18

  The present invention relates to a pyrimidine compound of the formula (I):wherein R1 represents a hydrogen atom, halogen atom or C1-C4 alkyl; R2 represents C3-C7 alkynyloxy; R3 represents a hydrogen atom, halogen atom or C1-C3 alkyl; X represents C4-C7 polymethylene, in which a CH?2#191-CH?2#191 may be replaced with a CH=CH, optionally substituted with at least one substituent selected from the group consisting of halogen atoms, trifluoromethyl and C1-C4 alkyls. This pyrimidine compound has an excellent activity of controlling pests.

  本发明涉及一种式（I）的嘧啶化合物：其中R1代表氢原子、卤原子或C1-C4烷基；R2代表C3-C7炔氧基；R3代表氢原子、卤原子或C1-C3烷基；X代表C4-C7聚甲烯基，在其中一个CH2-CH2可能被替换为CH=CH，可选择地取代至少一个卤原子、三氟甲基和C1-C4烷基的取代基。这种嘧啶化合物具有出色的控制害虫活性。
• Quinazoline potassium channel inhibitors
  申请人：Trotter Wesley B.

  公开号：US20070054894A1

  公开（公告）日：2007-03-08

  The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

  本发明涉及具有结构（I）的化合物，用于作为钾通道抑制剂治疗心律失常等。
• Novel sEH Inhibitors and Their Use
  申请人：Ding Yun

  公开号：US20100069391A1

  公开（公告）日：2010-03-18

  The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme.

  本发明涉及新型sEH抑制剂及其在治疗由sEH酶介导的疾病中的应用。